HPV Vaccine in Patients with Cervical Neoplasia

by Nathan Fujita

A metanalysis published in Obstetrics and Gynecology, Vol 135, NO.5 May 2020 shows that patients with high grade Cervical Intraepithelial Neoplasia (CIN), a pre-cancerous lesion, may benefit from an HPV vaccine after the surgical diagnosis is made. Recurrent disease was decreased by more than 50% in the vaccinated group in the first 6-18 months after treatment.

View All Articles

This information is not meant as medical advice. It is provided solely for education. Our practice would be pleased to discuss your unique circumstances and needs as they relate to these topics.